Mobility & Vitality Lifestyle Program (MOVE UP)

January 10, 2020 updated by: Steven M. Albert, University of Pittsburgh

Health Promotion and Disease Prevention Research Center

MOVE UP is a weight management program for adults 60-75 in community settings led by trained community health workers.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

MOVE UP is a weight management program designed for adults who desire to lose weight and improve their overall health.

Topics include: Overall Health, Weight management, Healthy eating, Behavior change, Physical activity

Study Type

Interventional

Enrollment (Actual)

303

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States
        • Community Sites

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age 60-75 at time of program start
  2. Self-reporting < 60 minutes per week of moderate structured physical activity
  3. BMI >= 30 but < 40 for screen. In person measurement on site will allow for 27-45 as inclusion criteria.
  4. Able to consent for participation and data collection
  5. Medical release before start of Weight Management
  6. Ability to walk with or without an assistive device
  7. Can regularly attend sessions
  8. Has not had bariatric surgery over the past year, or current use of weight loss prescription drug.

Exclusion Criteria:

  1. Uncontrolled diabetes mellitus (FBS > 300 & A1C > 11%) [to be assessed by physician on medical release]
  2. Uncontrolled hypertension (SBP > 180/110) %) [to be assessed by physician on medical release]
  3. Recent hospitalization (past 6 months)
  4. Active treatment for cancer (other than non-melanoma skin cancer)
  5. Significant visual or hearing impairment
  6. Dementia/psychiatric disorder
  7. Inability to communicate in English/lack of translator

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MOVE UP Intervention
Subjects will participate in a healthy lifestyle weight management intervention focused on healthy eating and increasing physical activity
Weight management behavioral program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Physical Performance Battery
Time Frame: 1 year
Physical function objectively measured by Short Physical Performance Battery (SPPB) which includes gait speed, grip strength and chair stands, each ranked as 0-4 and summed for a total score of 0-12 units
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported Physical Function
Time Frame: 1 year
Physical function self-reported with the MOS-SF36 - questions are assigned points for total points ranging fom 0-36
1 year
Weight
Time Frame: 1 year
Weight in kilograms
1 year
Height
Time Frame: 1 year
Height measured in meters
1 year
BMI
Time Frame: 1 year
Calculated from objective measurements of height and weight above as weight in Kilograms divided height in meters-squared
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne B. Newman, MD, University of Pittsburgh

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 4, 2015

Primary Completion (Actual)

July 18, 2019

Study Completion (Actual)

July 18, 2019

Study Registration Dates

First Submitted

November 25, 2015

First Submitted That Met QC Criteria

January 13, 2016

First Posted (Estimate)

January 15, 2016

Study Record Updates

Last Update Posted (Actual)

January 14, 2020

Last Update Submitted That Met QC Criteria

January 10, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 1U48DP005001-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on MOVE UP

Subscribe